MedStartr is all about connecting, collaborating and creating the future of healthcare together. See what's out there, weigh in, get involved or post your innovative idea that will help improve healthcare. Most of all MedStartr is a global community of healthcare innovation doers, dreamers, investors and adopters that value impact. If that's you, we would love to help you in your mission.
We are so glad you are interested in this company! Let's get you signed in or signed up to get involved in healthcare innovation on MedStartr today.
How We Help
<p>We understand that dermatologists around the world are overwhelmed. Although you strive to help as many people as possible, your capacity is limited, and your waiting lists are often filled with trivial cases that could be handled offline. It’s completely understandable to feel frustrated when a patient visits you with late-stage melanoma, and all you can do is fight a losing battle against skin cancer.</p>
<p>We also recognize that diagnosing skin lesions can be very challenging. Just the other day, I spoke with a dermatologist who showed me a photo of a lesion. She thought it was seborrheic keratosis but wasn’t completely sure. After using our app, which indicated a high-risk lesion, she said, “Yeah, I’m not certain, but maybe the top right corner is starting to show melanoma, so I recommended having it removed.”</p>
<p>Having a second diagnostic opinion can help improve your accuracy, save more lives, and prevent unnecessary procedures for some patients.</p>
<p>AI accuracy:</p>
<ul>
<li>https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610</li>
<li>https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7</li>
</ul>
<p>We understand that dermatology clinics worldwide are overwhelmed with demand. While clinics strive to serve as many patients as possible, your resources are limited, and your waiting lists are often filled with routine cases that could be managed remotely. This limits your ability to prioritize in-person visits for cases that truly require it, such as those needing surgical intervention.</p>
<p>Costs escalate dramatically, and cases become more severe and complex when patients arrive with advanced-stage melanoma—turning what could have been a straightforward, early-stage operation into a difficult and often losing battle against skin cancer.</p>
<p>We also recognize the challenges dermatologists face when diagnosing ambiguous cases. Recently, I spoke with a dermatologist who shared a photo of a lesion she suspected might be seborrheic keratosis but wasn’t certain. After using our app, which flagged the lesion as high-risk, she decided to have it removed, suspecting early melanoma in a small area. This kind of second opinion tool can improve diagnostic accuracy, save more lives, and prevent unnecessary surgeries for benign conditions.</p>
<p>The emdee skin app, together with the Physician Console, helps prioritize patients and supports your dermatologists in making more precise diagnoses, ultimately enhancing patient care and clinic efficiency.</p>
<p>References:</p>
<ul>
<li>https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610</li>
<li>https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7</li>
</ul>
<p>We help skincare product manufacturers connect with the right audience. Our users are health-conscious and highly interested in quality skincare products. We educate them on protecting their skin from UV radiation. If you’re looking for a platform to promote your sunscreen cream, Emdee Skin is the perfect choice.</p>
Company Info
Clinical & IP
🔬
Clinical Validation
<p>We have two posts descrbing the efficiency of the AI:</p>
<p>https://medium.com/@attilaulbert/performance-of-the-regular-ai-of-emdee-skin-c7df6cf9e610</p>
<p>https://medium.com/@attilaulbert/the-performance-of-the-dermoscopic-ai-of-emdee-ai-4adb8e7ee6f7</p>
<p> </p>
MedStartr Engagement Score
?
24
The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment